Immunomedics, Inc. (IMMU) |
|---|
| $1.95 52 Week Low | $5.73 2017-04-28 15:02:45 MDT | $7.15 52 Week High |
| Healthcare Sector | Biotechnology Industry |
| Nasdaq Stock Exchange | United States Country |
| Market Cap: | $539,420,000 | Small Cap (Between $200M and $2B) |
| Analyst Recommendation: | 2 | Analysts say: Buy. (1=Strong Buy, 5=Strong Sell) |
| Beta: | 3.01 | Higher Volatility Stock (beta over 1). Stock will go up more when the market goes up, and go down more when the market goes down. Beta of 1 means stock would match the S&P 500 Index. |
ForwardPE: 254.25 | 5 Yr Est Growth: Unknown | Yield: 0.00% |
PEG-Y Ratio: N/A | Unknown PEG-Y ratio |
% Above 50 DayMA: -6.07% | % Above 200 DayMA: 35.14% |
IMMU Performance 52 Weeks: 52.85% | S&P 500 Performance 52 Weeks: 13.50% |
Mixed Trend. Short Term trend is down, but longer term trend is up. There is hope because 50 Day MA is still above 200 Day MA. Stock is closer to 52 Week High than 52 Week Low. | IMMU outperforming S&P 500 by 39.35% the last 52 Weeks. |
Price To Book: N/A | Unknown Price to Book Ratio |
EV to EBITDA: -10.28 | Unknown EV to EBITDA ratio |
| Field | Value | Average | Comments |
|---|---|---|---|
| % Held By Insiders | 6.84% | 17.28% | Held by fewer than average Insiders. |
| % Held By Institutions | 43.70% | 62.07% | Institutional percentage lower than average. Institutions may not have conviction in stock. Or is this a chance for institutions to invest more and boost price? |
| Short % Of Float | 23.86% | 07.02% | Shorted by greater than average percent. Investors and traders do not believe in stock. But watch out for short squeezes pushing stock upwards. |
| Debt to Equity | N/A | 1.08 | Unknown. |
| Profit Margin % | N/A | -00.18% | Unknown. |
| Operating Margin % | -2.00% | -05.28% | Operating Margin greater than average percent. Good. |
| Return on Equity % | N/A | -08.79% | Unknown. |
| Return on Assets % | -55.06% | -01.29% | Return on Assets less than average percent. Stock can do better than this? |
| Revenue Per Employee | $22,595.42 | $883,096.70 | Less than average Revenue Per Employee. This stock (or industry) might not be as efficient as others? Each industry might have a different standard. |
| Price to Cash | 13.02 | 5.52 | Higher than average Price to Cash. Meaning that the company has a lower percentage of cash as a percent of price. Cash can be good to cushion company during hard times, and as a potential source for buyouts or investments. However, some activists want the cash to be used by a company to buy its own stock, or to increase their dividend, or to invest the money. |
| CPEGY Ratio | N/A | 2.26 | Unknown. |
PROS:
| CONS:
|